Generally, FGFR3 alterations are well documented in UTUC and are typically associated with low T grade, non‐muscle‐invasive tumors and a favorable prognosis, further supporting our findings. Here, FGFR3 is linked to renal pelvis/ureter urothelial carcinoma.